Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1996 1
1998 2
1999 2
2001 2
2003 1
2005 2
2006 2
2007 2
2008 2
2009 1
2010 1
2011 1
2012 1
2013 4
2014 3
2015 1
2016 4
2018 1
2019 1
2020 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults.
Kared H, Wolf AS, Alirezaylavasani A, Ravussin A, Solum G, Tran TT, Lund-Johansen F, Vaage JT, Nissen-Meyer LS, Nygaard UC, Hungnes O, Robertson AH, Næss LM, Trogstad L, Magnus P, Munthe LA, Mjaaland S. Kared H, et al. Among authors: naess lm. Nat Commun. 2022 Jul 18;13(1):4165. doi: 10.1038/s41467-022-31888-y. Nat Commun. 2022. PMID: 35851055 Free PMC article.
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future.
Holst J, Oster P, Arnold R, Tatley MV, Næss LM, Aaberge IS, Galloway Y, McNicholas A, O'Hallahan J, Rosenqvist E, Black S. Holst J, et al. Among authors: naess lm. Hum Vaccin Immunother. 2013 Jun;9(6):1241-53. doi: 10.4161/hv.24129. Epub 2013 Mar 7. Hum Vaccin Immunother. 2013. PMID: 23857274 Free PMC article. Review.
T-cell responses against meningococcal antigens.
Næss LM, Oftung F, Aase A, Michaelsen TE, Pollard AJ. Næss LM, et al. Methods Mol Med. 2001;66:339-48. doi: 10.1385/1-59259-148-5:339. Methods Mol Med. 2001. PMID: 21336766
Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.
Norheim G, Mueller JE, Njanpop-Lafourcade BM, Delrieu I, Findlow H, Borrow R, Xie O, Nagaputra J, Ramasamy R, Dold C, Tamekloe TA, Rollier CS, Watt H, Kere AB, Næss LM, Pollard AJ. Norheim G, et al. Among authors: naess lm. Vaccine. 2018 Feb 28;36(10):1297-1303. doi: 10.1016/j.vaccine.2018.01.031. Epub 2018 Feb 2. Vaccine. 2018. PMID: 29397226 Free article.
Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults: A Randomized Clinical Trial.
Pleguezuelos O, Dille J, de Groen S, Oftung F, Niesters HGM, Islam MA, Næss LM, Hungnes O, Aldarij N, Idema DL, Perez AF, James E, Frijlink HW, Stoloff G, Groeneveld P, Hak E. Pleguezuelos O, et al. Among authors: naess lm. Ann Intern Med. 2020 Apr 7;172(7):453-462. doi: 10.7326/M19-0735. Epub 2020 Mar 10. Ann Intern Med. 2020. PMID: 32150750 Clinical Trial.
40 results